Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Sort by:
Need a comprehensive medical report on "University of Cologne"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
Not Applicable
Completed
- Conditions
- Attention-Deficit/Hyperactivity Disorder
- Interventions
- Behavioral: CBT Based Self-help Workbook + Counseling Telepho
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 50
- Registration Number
- NCT01660464
- Locations
- 🇩🇪
Department of Child and Adolescent Psychiatry and Psychotherapy at the University of Cologne, Cologne, NRW, Germany
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
- Conditions
- Guillain-Barre SyndromeMultifocal Motor NeuropathyCIDP
- First Posted Date
- 2012-08-01
- Last Posted Date
- 2014-12-12
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 50
- Registration Number
- NCT01655394
- Locations
- 🇩🇪
University of Cologne, Cologne, Germany
Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides
Phase 1
- Conditions
- CD30 Positive Cutaneous T Cell LymphomaCD30 Positive Transformed Mycosis Fungoides
- Interventions
- Genetic: Genetically modified T cells # 1138
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2012-07-20
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 15
- Registration Number
- NCT01645293
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, Germany
A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)
Completed
- Conditions
- Molybdenum Cofactor Deficiency
- First Posted Date
- 2012-07-16
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Origin Biosciences
- Target Recruit Count
- 15
- Registration Number
- NCT01640717
- Locations
- 🇺🇸
Vanderbilt Children's Hospital, Nashville, Tennessee, United States
🇦🇺Neonatologist, Department of Paediatrics, Mercy Hospital for Women, Heidelberg, Australia
🇬🇧Birmingham Children's Hospital, Birmingham, United Kingdom
Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- Dr. Falk Pharma GmbH
- Target Recruit Count
- 123
- Registration Number
- NCT01627262
- Locations
- 🇩🇪
Ev. Krankenhaus Kalk, University of Cologne, Köln, Germany
International Guillain-Barré Syndrome Outcome Study
Completed
- Conditions
- Guillain-Barré SyndromeMiller Fisher Syndrome
- First Posted Date
- 2012-04-23
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT01582763
- Locations
- 🇺🇸
Barrows Neurological Institute, Phoenix, Arizona, United States
🇺🇸UC Irvine Health, Orange, California, United States
🇺🇸Yale University School of medicine, New Haven, Connecticut, United States
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma
Phase 2
Completed
- Conditions
- Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2012-04-03
- Last Posted Date
- 2018-10-29
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 100
- Registration Number
- NCT01569204
- Locations
- 🇩🇪
1st Dept. of Medicine, Cologne University Hospital, Cologne, Germany
Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury
Phase 3
Completed
- Conditions
- Chronic Renal Failure/ Kidney DiseaseContrast-medium Induced Acute Kidney Injury
- Interventions
- Dietary Supplement: White wineDietary Supplement: Red wineDietary Supplement: Beer
- First Posted Date
- 2012-03-26
- Last Posted Date
- 2013-07-08
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 260
- Registration Number
- NCT01562925
- Locations
- 🇩🇪
Herzzentrum der Universität zu Köln, Cologne, Germany
A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
Phase 1
Completed
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 22
- Registration Number
- NCT01558167
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, Germany
Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients
Not Applicable
Completed
- Conditions
- Bloodstream Infection
- Interventions
- Device: 3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2015-12-09
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 630
- Registration Number
- NCT01544686
- Locations
- 🇩🇪
Universitätsklinikum Aachen, Aachen, NRW, Germany
🇩🇪University Hospital Cologne, Cologne, NRW, Germany
🇩🇪Universitätsmedizin Berlin - Charité, Berlin, Germany
© Copyright 2025. All Rights Reserved by MedPath